Carl Zeiss Meditec Stock Target Price
CZMWF Stock | USD 61.22 0.01 0.02% |
Carl Zeiss Meditec fundamentals help investors to digest information that contributes to Carl Zeiss' financial success or failures. It also enables traders to predict the movement of Carl Pink Sheet. The fundamental analysis module provides a way to measure Carl Zeiss' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Carl Zeiss pink sheet.
Carl |
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
All Next | Launch Module |
Carl Fundamentals
Return On Equity | 0.16 | |||
Return On Asset | 0.0955 | |||
Profit Margin | 0.15 % | |||
Operating Margin | 0.21 % | |||
Current Valuation | 12.07 B | |||
Shares Outstanding | 89.44 M | |||
Shares Owned By Insiders | 59.10 % | |||
Shares Owned By Institutions | 22.23 % | |||
Price To Earning | 75.63 X | |||
Price To Book | 6.17 X | |||
Price To Sales | 6.34 X | |||
Revenue | 1.9 B | |||
Gross Profit | 1.13 B | |||
EBITDA | 419.49 M | |||
Net Income | 293.91 M | |||
Cash And Equivalents | 8.4 M | |||
Cash Per Share | 0.09 X | |||
Total Debt | 120.05 M | |||
Debt To Equity | 0.07 % | |||
Current Ratio | 3.35 X | |||
Book Value Per Share | 22.53 X | |||
Cash Flow From Operations | 188.2 M | |||
Earnings Per Share | 2.93 X | |||
Price To Earnings To Growth | 3.93 X | |||
Target Price | 138.8 | |||
Number Of Employees | 4.22 K | |||
Beta | 0.8 | |||
Market Capitalization | 12.53 B | |||
Total Asset | 2.4 B | |||
Retained Earnings | 458 M | |||
Working Capital | 573 M | |||
Current Asset | 859 M | |||
Current Liabilities | 286 M | |||
Z Score | 62.4 | |||
Annual Yield | 0.01 % | |||
Net Asset | 2.4 B | |||
Last Dividend Paid | 1.1 |
About Carl Zeiss Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Carl Zeiss Meditec's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Carl Zeiss using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Carl Zeiss Meditec based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Carl Pink Sheet
Carl Zeiss financial ratios help investors to determine whether Carl Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carl with respect to the benefits of owning Carl Zeiss security.